gms | German Medical Science

81st Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

12.05. - 16.05.2010, Wiesbaden

Endoscopic diode laser polypectomy for treatment of nasal polyposis

Meeting Abstract

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 81st Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Wiesbaden, 12.-16.05.2010. Düsseldorf: German Medical Science GMS Publishing House; 2010. Doc10hno091

doi: 10.3205/10hno091, urn:nbn:de:0183-10hno0910

Published: July 6, 2010

© 2010 Caffier et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Introduction: The goal of our clinical trial was to investigate the effect of diode laser polypectomy and subsequent topical corticosteroid application in recurrent nasal polyposis.

Patients and methods: Nineteen otherwise therapy-refractory nasal polyposis patients suffering from nasal obstruction and olfactory dysfunction underwent videoendoscopic diode laser polypectomy under topical anesthesia. After the first postoperative week, 250 µg beclomethasone dipropionate aerosol spray was self-administered into each nostril (1-0-1). Therapeutic efficacy was evaluated after 6 weeks, 12 weeks, and at regular 3-month intervals based on photodocumentation, rhinomanometry, and visual analog scales (VAS).

Results: After 6 and 12 weeks, subjective and objective data indicated a significant improvement of nasal obstruction and olfactory dysfunction. Laser surgery and topical beclomethasone dipropionate application were well tolerated. Throughout long-term follow-up (median 32 months), 21% of our patients developed a persisting disappearance of nasal polyps.

Conclusion: Minimally invasive endonasal diode laser polypectomy combined with topical high-dose corticosteroid application represents a symptom-oriented outpatient treatment option in therapy-refractory nasal polyposis.